USE OF CHONDROITIN SULPHATE E (CS-E ) FOR THE TREATMENT DISEASES OR CONDITIONS RELATED TO COLLAGEN FIBRIL FORMATION.

摘要

The present invention comprises the use of chondroitin sulphate (CS-E) or an active fragment thereof for the treatment of diseases or conditions related to collagen fibril formation. Said compounds can be administrated either by oral, topical, injectable or by any other suitable route.